UNSPSC 42161608: Hemodialysis dialysate solutions

In this classification, this commodity indicates a product used as a dialysate solution meter in a hemodialysis procedure in a medical setting. US FDA regulates Hemodialysis dialysate solutions under 21 CFR 876.5820 and under FDA product code KPO. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42161608 Hemodialysis dialysate solutions is a Commodity code that captures fluid formulations used in renal replacement therapy, but recent state and local procurement activity under this code shows minimal relevant solicitation volume. The two opportunities tagged to this code in the recent record—a NASPO ValuePoint cooperative medical supplies RFP and a Sourcewell law enforcement equipment procurement—do not represent dialysate-specific demand; the first encompasses broad medical supplies across multiple product categories, and the second addresses law enforcement equipment entirely unrelated to dialysate formulations. State and local governments do purchase dialysate through group purchasing organizations and cooperative vehicles such as NASPO ValuePoint and Sourcewell, but the recent posting activity does not isolate or emphasize dialysate as a line item or standalone procurement driver.

The geographic and issuing-body signals are similarly diffuse. The NASPO ValuePoint opportunity references Idaho state agencies and participating entities across the consortium's multi-state footprint, while the Sourcewell opportunity spans Washington state counties (Franklin, Grant, Grays Harbor, Chelan, Yakima) and a national network of jurisdictions and tribal governments. Neither opportunity provides dialysate-specific scope, pricing, or volume signals. Prospective vendors should monitor cooperative purchasing consortia catalogs and framework agreements rather than rely on isolated RFP postings under this code; dialysate demand typically flows through established group-purchase pricing agreements rather than dedicated solicitations. The minimal recent activity suggests either that dialysate procurement is consolidated under broader medical-supply codes or that state and local buyers source through pre-negotiated national contracts and cooperative vehicles outside the traditional RFP cycle.